Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Italy Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20041
20051
20062
20075
20085
200911
20104
20116
20127
20135
20142
20155
20164
20175
20187
20198
20201
20217
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer14
Bristol-Myers Squibb5
Hoffmann-La Roche5
University of Milan5
Eli Lilly and Company4
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)2
BeiGene2
Cardarelli Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular96
Liver Neoplasms21
Neoplasms9
Carcinoma5
Fibrosis5
Carcinoma, Non-Small-Cell Lung4
Liver Diseases4
Colorectal Neoplasms3
Hepatitis C3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.